SRH Wald-Klinikum Gera

Hospital


Location: Gera, Germany (DE) DE

ISNI: 0000000102147565

ROR: https://ror.org/00q236z92

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Incidence of bleeding in 8172 percutaneous ultrasound-guided intraabdominal diagnostic and therapeutic interventions - results of the prospective multicenter DEGUM interventional ultrasound study (PIUS study) (2015) Strobel D, Bernatik T, Blank W, Will U, Reichel A, Wuestner M, Keim V, et al. Journal article Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial (2014) Von Minckwitz G, Schneeweiss A, Loibl S, Salat C, Denkert C, Rezai M, Blohmer JU, et al. Journal article Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features (2014) Barthelmeß S, Geddert H, Boltze C, Moskalev E, Bieg M, Sirbu H, Brors B, et al. Journal article Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing (2014) Moskalev E, Frohnauer J, Merkelbach-Bruse S, Schildhaus HU, Dimmler A, Schubert T, Boltze C, et al. Journal article Phenotypical and molecular distinctness of sinonasal haemangiopericytoma compared to solitary fibrous tumour of the sinonasal tract (2014) Agaimy A, Barthelmeß S, Geddert H, Boltze C, Moskalev E, Koch M, Wiemann S, et al. Journal article PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer (2014) Loibl S, Von Minckwitz G, Schneeweiss A, Paepke S, Lehmann A, Rezai M, Zahm DM, et al. Journal article Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing (2013) Moskalev E, Stöhr R, Rieker R, Hebele S, Fuchs F, Sirbu H, Mastitsky SE, et al. Journal article Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma" (2013) Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, et al. Journal article